semaglutide sales 2024 Market Size, Share, Demand, Forecast, 2034 Semaglutide Market Report: Size, Growth,
Description
Esto puede suceder con semaglutida, pero tambin con otros tratamientos como la insulina
5 (2023): 9981004, 10.2337/dc22-1710
A recent meta-analysis of 11 cardiovascular outcome trials involving 55,921 patients treated with GLP-1 RAs and 43,306 patients treated with DPP-4 inhibitors also revealed no significant association between either drug class and pancreatic cancer risk
Reported waiting times range from 3 to 6 months in some Integrated Care Boards, 9 to 18 months in many, and over 2 years in others
Evidence is growing that these are not rare side-effects
